HomeQTbreasthealthLatest QTbreasthealth Center Now Open within Scottsdale's Vincere Cancer Center

Latest QTbreasthealth Center Now Open within Scottsdale’s Vincere Cancer Center

QTbreasthealth™ has announced its debut in Scottsdale at the Vincere Cancer Center, bringing radiation-free and compression-free breast imaging technology to women in a unique patient-centric environment.

Unlike traditional breast imaging modalities, the QTscan™ has no radiation, no compression, and no injections. The company’s mission is to make the technology commercially available to women who haven’t had access to this kind of solution before.

QTscan has received FDA 510(k) clearance for breast imaging and is not a replacement for screening mammography. The FDA has also granted QT Ultrasound Breakthrough Device designation for its QT Scanner, potentially offering new opportunities for earlier and more frequent screening for young women at high risk for breast cancer who have no available FDA-cleared screening options.

“For women with dense breasts, or a personal or family history of breast cancer, QTbreasthealth allows them to make more informed decisions about their health and wellness,” said QTbreasthealth President Meg Donigan.  “About half of all women have dense breasts and may have gotten false positives with mammography, or been told they need additional imaging. The QTscan is an excellent follow-up imaging option because we can see through dense breasts and identify suspicious areas, which mammography may not.”

In January 2019, parent company QT Ultrasound announced the opening of QTbreasthealth™ imaging centers to provide women with a best-in-class experience built around the company’s groundbreaking quantitative transmission (QT) ultrasound technology.  The QTbreasthealth network currently includes five centers: Novato, San Jose, and Walnut Creek, CA; Grand Rapids, Michigan; and now Scottsdale, AZ.

“I believe in a comprehensive, integrative, patient-centered approach for each patient I treat, including access to the most medically advanced screenings for breast health,” added Radiation Oncology Specialist Dr. Vershalee Shukla, MD, who is co-founder of the Vincere Cancer Center in Scottsdale.  “I see QTbreasthealth as the perfect complement to my practice philosophy, one that empowers my patients.  We are thrilled to welcome them to Vincere Cancer Center.”

In addition to being radiation-free and compression-free, the QTbreasthealth experience delivers results quickly via a private consultation with a healthcare provider.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy